Literature DB >> 15308549

C-reactive protein, fibrin D-dimer, and risk of ischemic heart disease: the Caerphilly and Speedwell studies.

G D O Lowe1, P M Sweetnam, J W G Yarnell, A Rumley, C Rumley, D Bainton, Y Ben-Shlomo.   

Abstract

BACKGROUND: There is increasing interest in the predictive value of C-reactive protein (CRP) and fibrin D-dimer in the prediction of ischemic heart disease (IHD). We assessed their joint and independent associations with IHD in a large combined analysis of 2 population cohorts. METHODS AND
RESULTS: Men aged 49 to 66 years from the general populations of Caerphilly and Speedwell were studied between 1982 and 1988 and re-examined for new IHD events at fixed intervals of approximately 105 months (Caerphilly) and 75 months (Speedwell). 3213 men had CRP and D-dimer measured at baseline and 351 (11%) had a new IHD event. Mean levels of CRP and D-dimer were significantly higher among men in whom IHD developed. The relative odds of IHD in men in the top 20% of the distribution of CRP was 2.97 (95% CI, 2.04, 4.32) and for D-dimer was 2.40 (95% CI, 1.69, 3.40); CRP and D-dimer had additive effects on risk of IHD. Multivariate analysis reduced the size of the relative odds, which remained significant for D-dimer.
CONCLUSIONS: Both inflammatory and thrombogenic markers are important (and potentially additive) predictors of coronary risk.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15308549     DOI: 10.1161/01.ATV.0000141842.27810.a9

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  16 in total

Review 1.  The use of high-sensitivity assays for C-reactive protein in clinical practice.

Authors:  Kiran Musunuru; Brian G Kral; Roger S Blumenthal; Valentin Fuster; Catherine Y Campbell; Ty J Gluckman; Richard A Lange; Eric J Topol; James T Willerson; Milind Y Desai; Michael H Davidson; Samia Mora
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-08-19

2.  A genetic association study of D-dimer levels with 50K SNPs from a candidate gene chip in four ethnic groups.

Authors:  Lu-Chen Weng; Weihong Tang; Stephen S Rich; Nicholas L Smith; Susan Redline; Christopher J O'Donnell; Saonli Basu; Alexander P Reiner; Joseph A Delaney; Russell P Tracy; Cameron D Palmer; Taylor Young; Qiong Yang; Aaron R Folsom; Mary Cushman
Journal:  Thromb Res       Date:  2014-05-20       Impact factor: 3.944

3.  Inflammatory biomarkers and abacavir use in the Women's Interagency HIV Study and the Multicenter AIDS Cohort Study.

Authors:  Frank J Palella; Stephen J Gange; Lorie Benning; Lisa Jacobson; Robert C Kaplan; Alan L Landay; Russell P Tracy; Richard Elion
Journal:  AIDS       Date:  2010-07-17       Impact factor: 4.177

4.  Changes in haemostatic and platelet activation markers in non-dipper hypertensive patients.

Authors:  Athanasia Agorasti; Efthimia Mourvati; Theodoros Trivellas; Vasilios Papadopoulos; Ioanna Bazntiara; Anna Christoforidou; Ploumis Passadakis
Journal:  Int Urol Nephrol       Date:  2011-03-09       Impact factor: 2.370

5.  Shiftwork and Biomarkers of Subclinical Cardiovascular Disease: The BCOPS Study.

Authors:  Meghan M Holst; Michael D Wirth; Anna Mnatsakanova; James B Burch; Luenda E Charles; Cathy Tinney-Zara; Desta Fekedulegn; Michael E Andrew; Tara A Hartley; John M Violanti
Journal:  J Occup Environ Med       Date:  2019-05       Impact factor: 2.162

6.  Sex and ethnic differences in 47 candidate proteomic markers of cardiovascular disease: the Mayo Clinic proteomic markers of arteriosclerosis study.

Authors:  Charles X Kim; Kent R Bailey; George G Klee; Allison A Ellington; Guanghui Liu; Thomas H Mosley; Hamid Rehman; Iftikhar J Kullo
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

7.  The association between blood coagulation activity and lung function: a population-based study.

Authors:  Andrew W Fogarty; Sarah A Lewis; Tricia M McKeever; Gordon D O Lowe; Lorna Clark; John Britton
Journal:  PLoS One       Date:  2010-11-16       Impact factor: 3.240

8.  Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease.

Authors:  Paul Elliott; John C Chambers; Weihua Zhang; Robert Clarke; Jemma C Hopewell; John F Peden; Jeanette Erdmann; Peter Braund; James C Engert; Derrick Bennett; Lachlan Coin; Deborah Ashby; Ioanna Tzoulaki; Ian J Brown; Shahrul Mt-Isa; Mark I McCarthy; Leena Peltonen; Nelson B Freimer; Martin Farrall; Aimo Ruokonen; Anders Hamsten; Noha Lim; Philippe Froguel; Dawn M Waterworth; Peter Vollenweider; Gerard Waeber; Marjo-Riitta Jarvelin; Vincent Mooser; James Scott; Alistair S Hall; Heribert Schunkert; Sonia S Anand; Rory Collins; Nilesh J Samani; Hugh Watkins; Jaspal S Kooner
Journal:  JAMA       Date:  2009-07-01       Impact factor: 56.272

Review 9.  Association between serum level of C-reactive protein and risk of cardiovascular events based on cohort studies.

Authors:  Xingjin Yang; Dongdong Zhang; Yang Zhao; Dechen Liu; Quanman Li; Chunmei Guo; Gang Tian; Minghui Han; Ranran Qie; Shengbing Huang; Qionggui Zhou; Yang Zhao; Yifei Feng; Xiaoyan Wu; Yanyan Zhang; Yang Li; Yuying Wu; Cheng Cheng; Dongsheng Hu; Liang Sun
Journal:  J Hum Hypertens       Date:  2021-05-12       Impact factor: 3.012

10.  Serum concentration of C-reactive protein is not a good marker of bronchial hyperresponsiveness.

Authors:  Bernard Panaszek; Ewa Liebhart; Jerzy Liebhart; Robert Pawłowicz; Andrzej M Fal
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007 Sep-Oct       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.